Nov 23 (Reuters) - Bill Ackman's Pershing Square (N:SQ) Capital
Management raised its stake in Valeant Pharmaceuticals (N:VRX)
International Inc VRX.TO VRX.N to 9.9 percent, making it the
second largest shareholder in the company.
The hedge fund firm previously held a stake of 5.7 percent
in the drug maker. (http://1.usa.gov/1LwwmGG)